Wednesday, 07 December 2022

 

 

LATEST NEWS Eye & health Check-up camp test organized at Brookfield International School Mann government committed to solve grievances of people state: Kuldeep Singh Dhaliwal Newly appointed Member of CBFC calls on Governor Will shortly solve legitimate demands of Panchayats Secretaries : Kuldeep Singh Dhaliwal MLA, DC and CP flag off two ambulances for stray dogs’ treatment Zonal level conference held on 'National Logistics Policy' Punjab Government To Set Up 20 Dedicated Rural Industrial Hubs In The State: Bhagwant Mann International volunteers Day celebrated in Srinagar My Town My Pride : Visiting officers inspect developmental works at MC Handwara, MC Langate 60th Annual Raising Day of Civil Defense & Home Guards celebrated at Srinagar Director Agriculture Kashmir Chowdhary Mohammad Iqbal chairs meeting of Organic/ Bio fertilizer companies Habitual Timber Smugglers to be booked under PSA : Sachin Kumar Vaishya Two day ‘My Town My Pride’ 2.0 concludes at Hajin My Town My pride 2.0 concludes at Shopian My Town My Pride : DC Shopian Sachin Kumar Vaishya chairs joint meeting of ULB Members, Officers Div Com Kashmir inaugurates CBC’s 5-day Multimedia Exhibition on Amrit Mahotsav at Anantnag Welfare of forest workers top priority with State Government : Lal Chand Kataruchak Step closer to resolve Fazilka bus stand issue: Laljit Singh Bhullar instructs to initiate process of shifting bus stand to transport department Harmony is the strength of India's culture : Rajendra Vishwanath Arlekar Dr. Ambedkar paid tribute on the occasion of Mahaparinirvan Divas in Punjab Vidhan Sabha Punjab Government released Rs. 267 lakh for update of M.R. Homes for patients suffering from psychological problems: Dr. Baljit Kaur

 

Study reveals obesity drug may decrease type 2 diabetes risk

Health, Study, New York, Research, Researchers, World News

Web Admin

Web Admin

5 Dariya News

New York , 12 Sep 2022

The risk of type 2 diabetes is more than halved by weekly injections of the new obesity drug semaglutide, which was recently approved in the US and has been provisionally approved in England, says a new study.

The researchers of the study, to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD), said semaglutide reduces the future risk of diabetes by over 60 per cent in patients with obesity.

"Semaglutide appears to be the most effective medication to date for treating obesity and is beginning to close the gap with the amount of weight loss following bariatric surgery," said researcher W. Timothy Garvey from the University of Alabama at Birmingham in the US.

Obesity is known to increase the risk of type 2 diabetes at least six-fold and the team was interested in understanding whether semaglutide could reduce this risk. To learn more, they conducted a new analysis of the data from two trials of semaglutide.

In STEP 1, 1,961 overweight or obese participants received an injection of 2.4 mg of semaglutide or a placebo weekly, for 68 weeks.STEP 4 involved 803 participants with overweight or obesity. All received weekly injections of 2.4 mg semaglutide for 20 weeks. 

They then either remained on semaglutide or were switched to placebo for the next 48 weeks.In STEP 1 participants receiving semaglutide, 10-year risk scores for type 2 diabetes decreased by 61 per cent (from 18.2 per cent at week 0 to 7.1 per cent at week 68). 

This compares to a 13 per cent reduction in risk score for those given the placebo (17.8 per cent at week +0 to 15.6 per cent at week 68).In the STEP 4 participants, the largest decreases in risk scores were seen in the first 20 weeks (from 20.6 per cent at week 0 to 11.4 per cent at week 20). 

In those who continued receiving semaglutide, the risk score decreased further to 7.7 per cent but in those who were switched to placebo, it rose to 15.4 per cent.

 

Tags: Health , Study , New York , Research , Researchers , World News

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD